Polyhemoglobin-tyrosinase, an oxygen carrier with murine B16F10 melanoma suppression properties: A preliminary report

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 32, Issue 2, 2004, Pages 293-302

  Yu, Binglan ^a   Chang, Thomas Ming Swi ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b Artif Cells and Organs Res Center   (Canada)

^c Fonds de la Recherche en Sante du Quebec   (Canada)

Author keywords

B16F10 murine melanoma; Cross linking; Polyhemoglobin tyrosinase; Systemic tyrosine; Tyrosinase

Indexed keywords

BLOOD; CELL CULTURE; CELLS; TUMORS;

INTRAVENOUS INJECTION; OXYGEN CARRIERS;

BIOTECHNOLOGY;

HEMOGLOBIN; MONOPHENOL MONOOXYGENASE; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; MELANOMA B16; MELANOMA B16F10; MELANOMA CELL; MOUSE; NONHUMAN; PROTEIN CROSS LINKING; PROTEIN RESTRICTION; TUMOR GROWTH;

ALDEHYDES; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CROSS-LINKING REAGENTS; FEMALE; HEMOGLOBINS; MELANOMA, EXPERIMENTAL; MICE; MONOPHENOL MONOOXYGENASE; OXYGEN CONSUMPTION; TYROSINE;

ANIMALIA; MURINAE;

EID: 3042593301     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIO-120037834     Document Type: Article

References (26)

1. Barthelmes, H. U., Niederberger, E., Roth, T., Schulte, K., Tang, W. C., Boege, F., Fiebig, H. H., Eisenbrand, G., Marko, D. (2001). Lycobetaine acts as a selective topoisomerase IIβ poison and inhibits the growth of human tumor cells. Br. J. Cancer 85:1585-1591.
2. Beahers, O. H., Henson, D. E., Hutter, R. V. P., Kennedy, B. J. (1992). Malignant melanoma of the skin (excluding eyelid). American Joint Committee on Cancer Manual for Staging of Cancer. 4th ed. Philadelphia: JB Lippincott, 143-148.
3. Borden, E. C., ed. (2002). Melanoma: Biologically Targeted Therapeutics. Totowa, NJ: Humana Press, pp. 39-72.
4. Burd, R., Lavorgna, S. N., Daskalakis, C., Wachsberger, P. R., Wahl, M. L., Biaglow, J. E., Stevens, C. W., Leeper, D. B. (2003). Tumor oxygenation and acidification are increased in melanoma xenografts after exposure to hyperglycemia and meta-lodobenzylguanidine. Radiat. Res. 159:328-335.
5. Chang, T. M. S. (1997). Blood Substitutes: Principles, Methods, Products and Clinical Trials. Vol. I. Basel, New York: Karger Publisher, (available for free access on www.artcell.mcgill.ca).
6. Chang, T. M. S. (2000). Red blood cell substitutes. Best Pract. Res. Clin. Haematol. 13:651-668.
7. Chang, T. M. S. (2003). Future generations of red blood cell substitutes. J. Intern. Med. 253:527-535.
8. Cooper, J. S. (1998). The evolution of the role of radiation therapy in the management of mucocutaneous malignant melanoma. Hematol. Oncol. Clin. North Am. 12:849-862.
9. Duckworth, H. W., Coleman, J. E. (1970). Physiochemical and kinetic properties of mushroom tyrosinase. J. Biol. Chem. 245:1613-1625.
10. Fu, Y. M., Yu, Z. X., Pelayo, B. A., Ferrans, V. J., Meadows, G. G. (1999). Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency. Cancer Res. 59:758-765.
11. Gili, A., Thomas, P. D., Ota, M., Jimbow, K. (2000). Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity. Melanoma Res. 10:9-15.
12. Gould, S. A. (2002). The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J. Am. Coll. Surgeons 195:445-452.
13. Jimbow, K. (1998). Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway. J. Med. Sci. 73:105-110.
14. Kayaga, J., Souberbielle, B. E., Sheikh, N., Morrow, W. J., Scott-Taylor, T., Vile, R., Chong, H., Dalgleish, A. G. (1999). Anti-tumor activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumor cell vaccine. Gene Ther. 6:1475-1481.
15. Letellier, S., Garnier, J. P., Spy, J., Stoitchkov, K., Le Bricon, T., Baccard, M., Revol, M., Kerneis, Y., Bousquet, B. (1999). Development of metastases in malignant melanoma is associated with an increase in the plasma. Melanoma Res. 9:389-394.
16. Lorincz, A. B., Kuttner, R. E., Brandt, M. B. (1969). Tumor response to phenylalanine-tyrosine limited diets. J. Am. Diet. Assoc. 54:198-205.
17. Meadows, G. G., Pierson, H. F., Abdallah, R. M., Desai, P. R. (1982). Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy. Cancer Res 42:3056-3063.
18. Pelayo, B. A., Fu, Y. M., Meadows, G. G. (1999). Inhibition of B16BL6 melanoma invasion by tyrosine and phenylalanine deprivation is associated with decreased secretion of plasminogen activators and increased plaminogen activator inhibitors. Clin. Exp. Metastasis 17:841-848.
19. Pelayo, B. A., Fu, Y. M., Meadows, G. G. (2001). Decreased tissue plaminogen activator and increased plasminogen activator inhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine. Int. J. Oncol. 18:877-883.
20. Potterf, B. S., Hearing, V. J. (1998). Tyrosine transport into melanosomes is increased following stimulation of melanocyte differentiation. Biochem. Biophys. Res. Commun. 248:795-800.
21. Rodriguez-ayerbe, C., Smith-zubiaga, I. (2000). Effect of serum withdrawal on the proliferation of B16F10 melanoma cells. Cell Biol. Int. 24:279-283.
22. Sprung, J., Kindscher, J. D., Wahr, J. A., Levy, J. H., Monk, T. G., Moritz, M. W., O'Hara, P. J. (2002). The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial. Anesth. Analg. 94:799-808.
23. Squires, J. E. (2002). Artificial blood. Science 295:1002-1005.
24. Yu, B., Chang, T. M. S. (2004a). Effects of combined oral administration and intravenous injection on maintaining decreased systemic tyrosine levels in rats. Artif. Cells Blood Substit. Biotechnol. 32:129-147.
25. Yu, B., Chang, T. M. S. (2004b). In vitro and in vivo enzyme studies of polyhemoglobin-tyrosinase. Biotechnol. Bioeng. (in press).
26. Yu, B., Chang, T. M. S. (2004c). In vitro and in vivo effects of polyhemoglobin-tyrosinase on murine B16F10 melanoma. Melanoma Res. (in press).